Minority interest volatility
Minority interest spiked to 38% of PAT in Q4 due to abnormal subsidiary profit; guided to normalize to ~25%, but could remain lumpy.
medium · analyst_questionEntero Healthcare Solutions Limited — Q4 FY26
Entero Healthcare delivered a strong FY26, with revenue of ₹6,591 crore growing 31.5% YoY on a like-for-like basis, driven by 15.6% organic growth and 16% inorganic contribution.
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Integration of recent acquisitions
Seven acquisitions closed in FY26, including three in medtech; integration risks and retention of key personnel are critical.
medium · management_commentaryInterest cost headwinds
Finance costs rose as IPO funds were deployed; management expects stable near-term costs but sequential decline only over 2-3 years.
medium · analyst_questionDependence on IPM growth for organic outperformance
Organic growth multiplier vs IPM has compressed to ~1.4x from ~1.7x as IPM growth accelerated; any IPM slowdown could pressure organic growth.
low · data_observation